XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 85.5 |  |  | $ | 102.1 |  |  | $ | 231.7 |  |  | $ | 310.9 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (21.6) |  |  | (26.3) |  |  | (65.5) |  |  | (79.6) |
Less: Income from continuing operations allocated to participating securities | (0.3) |  |  | (0.3) |  |  | (0.6) |  |  | (0.9) |
Income from continuing operations attributable to Encompass Health common shareholders | 63.6 |  |  | 75.5 |  |  | 165.6 |  |  | 230.4 |
(Loss) income from discontinued operations, net of tax | (18.5) |  |  | 24.6 |  |  | 16.7 |  |  | 90.6 |
Less: Net income attributable to noncontrolling interests included in discontinued operations | — |  |  | (0.4) |  |  | (1.3) |  |  | (1.3) |
Less: Income from discontinued operations allocated to participating securities | — |  |  | (0.1) |  |  | (0.1) |  |  | (0.5) |
(Loss) income from discontinued operations attributable to Encompass Health common shareholders | (18.5) |  |  | 24.1 |  |  | 15.3 |  |  | 88.8 |
Net income attributable to Encompass Health common shareholders | $ | 45.1 |  |  | $ | 99.6 |  |  | $ | 180.9 |  |  | $ | 319.2 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 99.2 |  |  | 99.0 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.64 |  |  | $ | 0.76 |  |  | $ | 1.67 |  |  | $ | 2.32 |
Discontinued operations | (0.19) |  |  | 0.24 |  |  | 0.15 |  |  | 0.90 |
Net income | $ | 0.45 |  |  | $ | 1.00 |  |  | $ | 1.82 |  |  | $ | 3.22 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 85.5 |  |  | $ | 102.1 |  |  | $ | 231.7 |  |  | $ | 310.9 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (21.6) |  |  | (26.3) |  |  | (65.5) |  |  | (79.6) |
Income from continuing operations attributable to Encompass Health common shareholders | 63.9 |  |  | 75.8 |  |  | 166.2 |  |  | 231.3 |
(Loss) income from discontinued operations, net of tax | (18.5) |  |  | 24.6 |  |  | 16.7 |  |  | 90.6 |
Less: Net income attributable to noncontrolling interests included in discontinued operations | — |  |  | (0.4) |  |  | (1.3) |  |  | (1.3) |
(Loss) income from discontinued operations attributable to Encompass Health common shareholders | (18.5) |  |  | 24.2 |  |  | 15.4 |  |  | 89.3 |
Net income attributable to Encompass Health common shareholders | $ | 45.4 |  |  | $ | 100.0 |  |  | $ | 181.6 |  |  | $ | 320.6 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 100.5 |  |  | 100.2 |  |  | 100.3 |  |  | 100.1 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.63 |  |  | $ | 0.76 |  |  | $ | 1.66 |  |  | $ | 2.31 |
Discontinued operations | (0.18) |  |  | 0.24 |  |  | 0.15 |  |  | 0.89 |
Net income | $ | 0.45 |  |  | $ | 1.00 |  |  | $ | 1.81 |  |  | $ | 3.20 |
Schedule of Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 99.2 |  |  | 99.0 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.3 |  |  | 1.2 |  |  | 1.1 |  |  | 1.1 |
Diluted weighted average common shares outstanding | 100.5 |  |  | 100.2 |  |  | 100.3 |  |  | 100.1 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration